Effects of Reverse Natural Apophyseal Glides as Compared to Ventro-cranial Translatoric Glides in the Management of Upper Thoracic Spine Hypomobility.

Launched by FOUNDATION UNIVERSITY ISLAMABAD · May 28, 2025

Keywords

ClinConnect Summary

This clinical trial is studying two different treatments for people who have limited movement in their upper back, a condition known as upper thoracic spine hypomobility. The goal is to see which treatment—reverse natural apophyseal glides or ventro-cranial translatoric glides—can help reduce pain and improve how well patients can move their upper back.

To participate in this study, you need to be an adult between 18 and 39 years old and have specific movement limitations in your upper back. Unfortunately, if you have certain conditions like severe back issues, recent surgeries, or certain chronic pain syndromes, you wouldn’t be eligible to join the trial. If you do qualify, you can expect to attend regular therapy sessions where you will receive one of the two treatments being tested. This research is currently looking for participants, so it’s a great opportunity to explore a potential new way to manage your back pain and improve your movement.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Both male and females 2. Adults (18-39 years) 3. Upper Thoracic hypomobility (flexion \<20° or extension \<25° or side bending \<20° or rotation \<35°)
• Exclusion Criteria:
• • 1-Ankylosing spondylitis 2-History of Spinal Fusion or spinal surgery (discectomy/laminectomy etc.) 3-Degenerative disc disorders 4-Cervical radiculopathy, Scoliosis 5-Spinal Stenosis or Myelopathy 6-Recent fracture or surgery 7-TB of spine, Spondylolisthesis 8-Not able to attend regular therapy appointments 9-Fibromyalgia/myofascial pain syndrome